The agency estimates that the new standard will prevent up to 4,500 premature deaths in the first year of full enforcement.
After 15 or more years since quitting, the cancer risk reached 50% of that associated with continued smoking.
Racial and ethnic disparities, however, persisted for various cancers, including prostate, male lung and bronchus, and female colorectal cancer.
The agency says the ban has “the potential to significantly reduce disease and death” and reduce “youth experimentation and addiction’.”
Lower observed-to-expected ratios were seen for cases diagnosed at localized versus advanced stages.
The report highlights advances such as approval of 14 new anticancer therapeutics and the expansion of the use of 12 previously approved therapeutics.
The meta-analysis only shows a 110-day survival benefit for colorectal cancer screening with sigmoidoscopy.
Responses are moderately understandable, not readily actionable, and written at the college reading level.
Single-site cancer screening could save an additional 3.2 million to 5.1 million life-years with perfect adherence.
However, some increased risk seen for lung cancer and smoking-related cancers
Please login or register first to view this content.
Login Register